Kyushu University and a Fukuoka-based startup Kaiko Ltd. have co-developed a potential antigenic protein for use in new coronavirus vaccines. The group succeeded in culturing ‘Antigen S Protein,’ a new antigen artificially created inside silkworms. As for the next step, the team will partner with a pharmaceutical company to establish efficient mass production. Source: NHK
#fukuokacorona #fukuokacovid19
Catch all of our Kyushu & Fukuoka local news reports on Twitter, Instagram, and Facebook
Disclaimer: Fukuoka Now posts summaries of Kyushu area related news for the benefit of those who cannot read Japanese. Contents posted here are mostly summaries of publicly posted news stories from Japanese media organizations. Errors might occur during translation. Those errors are ours, and not the source’s. Photos and images are sourced separately and are for illustrative purposes only. Please use this form to send feedback and questions.
